Cholangiocarcinoma Clinical Trials in Meldola
2 recruitingMeldola, Italy
Showing 1–2 of 2 trials
Recruiting
Phase 2Phase 3
CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative Chemotherapy Versus Immediate Resection in patIents With resecTable BiliarY Tract Cancers (BTC) at High Risk for Recurrence
Biliary Tract CancerCholangiocarcinoma
Gruppo Oncologico del Nord-Ovest300 enrolled19 locationsNCT06037980
Recruiting
Phase 3
Study of Tinengotinib VS. Physician's Choice a Treatment of Subjects With FGFR-altered in Cholangiocarcinoma
Cholangiocarcinoma
TransThera Sciences (Nanjing), Inc.200 enrolled87 locationsNCT05948475